Noskapin "dak" (Noscapine)

Noscapine acts on the central nervous system, primarily as a sigma‑1 receptor agonist. By modulating neuronal activity in the brainstem cough centre, it suppresses the cough reflex without producing opioid‑type analgesia.

The dosage of Noskapin dak is determined by the prescribing clinician based on the patient’s age, weight, severity of cough, and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for noscapine during pregnancy and lactation are limited. It should be used only if the potential benefit outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike opioid‑based cough suppressants such as codeine, noscapine does not have significant analgesic or addictive properties. It offers cough relief through central sigma‑1 receptor modulation, making it a non‑opioid alternative with a different side‑effect profile.

Store Noskapin dak at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Noskapin dak is administered orally. The tablet or liquid is taken by mouth with or without food, according to the prescriber’s directions. Swallow tablets whole; if a liquid formulation is supplied, measure the dose with a calibrated device.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, serious skin conditions like Stevens‑Johnson syndrome, hepatic dysfunction, hematologic abnormalities, and, in very uncommon cases, seizures. Prompt medical attention is required if any of these occur.

Noskapin dak should be avoided in individuals with a known hypersensitivity to noscapine or any of the product’s excipients. Caution is also advised for patients with severe hepatic or renal impairment, and it is generally not recommended for pregnant or breastfeeding women unless clearly indicated by a physician.